Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. has initiated its IPO process on the Shanghai Stock Exchange's Sci-Tech Innovation Board, aiming to raise approximately 865 million yuan for its operations in the MRI equipment sector [1]. Company Overview - Jianxin Superconducting specializes in the research, production, and sales of core components for medical MRI equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for about 50% of the MRI equipment's core component costs [1]. - The company has established itself as the leading independent supplier of superconducting magnets globally, with a diverse product matrix that includes various types of superconducting magnets [1]. - In the permanent magnet sector, Jianxin is recognized as the largest supplier of MRI permanent magnets worldwide, offering high-quality products that are economically viable and suitable for grassroots medical systems [1][2]. Market Position - As of 2024, Jianxin holds a global market share of approximately 4.2%, ranking fifth among the top five superconducting magnet manufacturers, following Siemens Healthineers, GE Healthcare, Philips Healthcare, and United Imaging Healthcare [2]. - The company has formed strategic partnerships with renowned MRI equipment manufacturers, enhancing its supply chain and reducing delivery costs significantly [2]. Financial Overview - The company reported revenues of approximately 359 million yuan, 451 million yuan, and 425 million yuan for the years 2022, 2023, and 2024, respectively, with net profits of about 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan during the same periods [3]. - As of December 31, 2024, the total assets of the company are approximately 671.28 million yuan, with a debt-to-asset ratio of 29.48% [4]. - The company has maintained a consistent increase in net profit margins, with a basic earnings per share of 0.44 yuan for 2024, up from 0.28 yuan in 2022 [4]. Fundraising and Investment Plans - The funds raised from the IPO will be allocated to several key projects, including the production of nitrogen-free superconducting magnets and the development of new superconducting magnet technologies, with a total investment plan of approximately 869.97 million yuan [3].
健信超导科创板IPO“已受理” 主营医用磁共振成像设备核心部件研发及产销
智通财经网·2025-05-09 10:37